Article info
PDFEditorial commentary
Marked abnormalities of plasma protein biomarkers in Creutzfeldt-Jakob disease (CJD)
- Correspondence to Professor Simon Mead, MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London W1W 7FF, UK; s.mead{at}prion.ucl.ac.uk
Citation
Marked abnormalities of plasma protein biomarkers in Creutzfeldt-Jakob disease (CJD)
Publication history
- Received July 8, 2020
- Accepted July 15, 2020
- First published September 14, 2020.
Online issue publication
October 16, 2020
Article Versions
- Previous version (16 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.